CMS announced a new funding opportunity for development, improvement and expansion of quality measures for the Quality Payment Program. Over three years, the agency will provide up to $30 million in ...
The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
A national coverage decision (NCD) published on March 16, 2018 by the Center for Medicare and Medicaid Services (CMS) focuses attention on foundational challenges to integrating genomics into clinical ...
CMS’ Innovation Center is offering the third and final session of its ACO Accelerated Development Learning Sessions. ACO Accelerated Development Learning Sessions are designed to provide executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results